Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |